Literature DB >> 21575600

CHFR binds to and regulates MAD2 in the spindle checkpoint through its cysteine-rich domain.

Jennifer A Keller1, Elizabeth M Petty.   

Abstract

CHFR has been implicated as a tumor suppressor in a multitude of cancers. It was originally identified as a major component of the antephase checkpoint. Recently, CHFR was reported to interact with MAD2, an important component of the spindle assembly checkpoint, where CHFR knockdown resulted in mislocalization of MAD2 and disruption of the MAD2/CDC20 interaction. To further understand how CHFR interacts with MAD2, we deleted key functional domains of CHFR, and investigated the effect on MAD2 binding and function. Here we show that deletion of the cysteine-rich domain of CHFR is required for the CHFR/MAD2 interaction as well as proper localization of MAD2 in the cell. Furthermore, the cysteine-rich domain deletion exhibits impaired ability to promote the MAD2/CDC20 interaction, leading to an increase in mitotic defects relative to wild type CHFR. These data support a critical role for CHFR in the MAD2 spindle checkpoint. Furthermore, these data establish the cysteine-rich domain of CHFR as the essential domain for the CHFR/MAD2 interaction and for promoting interaction between MAD2 and CDC20 to inhibit the anaphase-promoting complex.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21575600      PMCID: PMC3114255          DOI: 10.1016/j.bbrc.2011.04.143

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Coding region polymorphisms in the CHFR mitotic stress checkpoint gene are associated with colorectal cancer risk.

Authors:  Hio Chung Kang; Il-Jin Kim; Sang-Geun Jang; Seung-Hyun Hong; Jung-Ah Hwang; Hai-Rim Shin; Jae-Gahb Park
Journal:  Cancer Lett       Date:  2008-02-18       Impact factor: 8.679

2.  MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells.

Authors:  L S Michel; V Liberal; A Chatterjee; R Kirchwegger; B Pasche; W Gerald; M Dobles; P K Sorger; V V Murty; R Benezra
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

3.  Chfr is required for tumor suppression and Aurora A regulation.

Authors:  Xiaochun Yu; Katherine Minter-Dykhouse; Liviu Malureanu; Wei-Meng Zhao; Dongwei Zhang; Carolin J Merkle; Irene M Ward; Hideyuki Saya; Guowei Fang; Jan van Deursen; Junjie Chen
Journal:  Nat Genet       Date:  2005-03-27       Impact factor: 38.330

4.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

5.  Orderly inactivation of the key checkpoint protein mitotic arrest deficient 2 (MAD2) during mitotic progression.

Authors:  Hoi Tang Ma; Randy Y C Poon
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157

6.  Mitotic arrest defective protein 2 expression abnormality and its clinicopathologic significance in human osteosarcoma.

Authors:  Ling Yu; Wei-Chun Guo; Sheng-Hao Zhao; Jin Tang; Jia-Lu Chen
Journal:  APMIS       Date:  2010-03       Impact factor: 3.205

7.  Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.

Authors:  Lisa M Privette; Maria E González; Lei Ding; Celina G Kleer; Elizabeth M Petty
Journal:  Cancer Res       Date:  2007-06-27       Impact factor: 12.701

8.  Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.

Authors:  Ivan Ahel; Dragana Ahel; Takahiro Matsusaka; Allison J Clark; Jonathon Pines; Simon J Boulton; Stephen C West
Journal:  Nature       Date:  2008-01-03       Impact factor: 49.962

9.  CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis.

Authors:  Lisa M Privette; Elizabeth M Petty
Journal:  Transl Oncol       Date:  2008-07       Impact factor: 4.243

10.  The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.

Authors:  Dongmin Kang; James Chen; Jim Wong; Guowei Fang
Journal:  J Cell Biol       Date:  2002-01-21       Impact factor: 10.539

View more
  3 in total

1.  The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses.

Authors:  Tara Byrne; Helen G Coleman; Janine A Cooper; W Glenn McCluggage; Amanda McCann; Fiona Furlong
Journal:  Oncotarget       Date:  2017-06-08

Review 2.  Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine.

Authors:  Sarah Derks; Arjen H G Cleven; Veerle Melotte; Kim M Smits; Johann C Brandes; Nilofer Azad; Wim van Criekinge; Adriaan P de Bruïne; James G Herman; Manon van Engeland
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

Review 3.  The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression.

Authors:  Cordell VanGenderen; Troy Anthony Alan Harkness; Terra Gayle Arnason
Journal:  Aging (Albany NY)       Date:  2020-08-15       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.